Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1538-7933.2003.00573.x/fullpdf
Reference33 articles.
1. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999
2. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy;Zangari;Blood,2001
3. Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications;Zangari;Blood Coagul Fibrinolysis,2002
4. Desai AA Vogelzang NJ Rini BI Ansari R Krauss S Stadler WM. A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma. Cancer 2002 95 1629 36
5. Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors;Kuenen;J Clin Oncol,2002
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DVT as the Initial Presentation of Multiple Myeloma: A Rare Case Report and Literature Review;Cureus;2023-07-28
2. Mechanisms Contributing to Acquired Activated Protein C Resistance in Patients Treated with Thalidomide: A Molecular Dynamics Study;Cardiovascular & Hematological Disorders-Drug Targets;2022-12
3. Potential mechanisms of resistance to current anti-thrombotic strategies in Multiple Myeloma;Cancer Drug Resistance;2022
4. Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide;Nature Reviews Clinical Oncology;2021-03-02
5. Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?;Journal of Thrombosis and Thrombolysis;2021-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3